"The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of dalbavancin 500 mg (Xydalba, Durata Therapeutics) for acute bacterial skin and skin structure infections (ABSSSI) in ad"...
Desonate is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.
Patients should be instructed to use Desonate for the minimum amount of time as necessary to achieve the desired results because of the potential for Desonate to suppress the hypothalamic-pituitary-adrenal (HPA) axis [see WARNINGS AND PRECAUTIONS]. Treatment should not exceed 4 consecutive weeks [see DOSAGE AND ADMINISTRATION].
DOSAGE AND ADMINISTRATION
Apply a thin layer to the affected areas two times daily and rub in gently. Discontinue use when control is achieved. If no improvement is seen within 4 weeks, reassessment of diagnosis may be necessary. Treatment beyond 4 consecutive weeks is not recommended. Do not use with occlusive dressings. Avoid contact with eyes or other mucous membranes.
For topical use only. Not for oral, ophthalmic, or intravaginal use.
Dosage Forms And Strengths
Gel, 0.05%; (0.5mg/g) desonide in a translucent to opaque gel
Storage And Handling
Desonate is a translucent to opaque gel supplied in 60g tubes in cartons containing 1x 60g tube (NDC 50419-828-06), or a 2 x 60g tube TwinPack (NDC 50419-828-12).
Store at 25°C (77°F); excursions permitted to15-30°C (59-86°F) [See USP Controlled Room Temperature].
Keep out of reach of children.
Manufactured for: Bayer HealthCare Pharmaceuticals Inc. Whippany, NJ 07981 Manufactured in Canada. Rev. 07/2014This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 8/7/2014
Additional Desonate Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.